Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: €16.35 M
• Last 3 months FTD volume: €60.15 M
• Last 12 months FTD volume: €0.26 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	€5.75 M	€0.21 B	🇺🇸 USA
Vertex Pharmaceuticals VRTX	€42.51 M	€96.84 M	🇺🇸 USA
AbbVie ABBV	€21.44 M	€0.10 B	🇺🇸 USA
Illumina ILMN	€5.81 M	€28.54 M	🇺🇸 USA
Biogen BIIB	€22.86 M	€94.5 M	🇺🇸 USA
Pfizer PFE	€24.63 M	€0.10 B	🇺🇸 USA
Johnson & Johnson JNJ	€54.31 M	€94.31 M	🇺🇸 USA
Eli Lilly LLY	€0.21 B	€0.37 B	🇺🇸 USA
Merck MRK	€33.81 M	€0.17 B	🇺🇸 USA